iTeos Therapeutics Inc (ITOS) Live Share Price, Invest From India

iTeos Therapeutics Inc Stock Performance

as on August 29, 2025 at 6:59 am IST

Day's Low
$10.14
Day's Price Range
$10.17
$10.17
0.29%
Downside
52 Week's Low
52 Week's High
$9.91
52-Week Price Range
$10.47
$10.17
2.56%
Downside
2.95%
Upside

iTeos Therapeutics Inc share price movements today

Previous Close: $10.13
Open: $10.14
Volume: 5.1M
Day's Low - High: $10.14 - $10.17
52 Week Low - High: $9.91 - $10.47

iTeos Therapeutics Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

iTeos Therapeutics Inc Stock Fundamentals & Key Indicators

Check iTeos Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

iTeos Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of iTeos Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
iTeos Therapeutics Inc	BUY	$-	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$37.7B	57.21%	71.21	12.55%	NA
BeOne Medicines Ltd. (ADR)	NA	$27.3B	NA	59.56	8.94%	NA
Vertex Pharmaceuticals Inc.	BUY	$116.5B	140.42%	27.22	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$63.7B	13.39%	14.85	29.65%	0.58%

Analyst Recommendation on iTeos Therapeutics Inc Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for iTeos Therapeutics Inc. Average target price of $10.3

iTeos Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on iTeos Therapeutics Inc.

What analysts predicted

1.26%UPSIDE

Target Price

$10.3

Current Price

$10.17

Analyzed by

11 Analysts

Target

$10.30

iTeos Therapeutics Inc target price $10.3, a slight upside of 1.26% compared to current price of $10.17. According to 11 analysts rating.

iTeos Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	12	-	-	-11	-	35	-	-	-	-
Gross Profit	12	0	0	-11	0	34	0	-34	0	-
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-15	-34	-32	-30	-38	-7	-45	-43	-34	-78
Net Profit Margin	-123.47%	0.00%	0.00%	270.29%	0.00%	-20.37%	0.00%	0.00%	0.00%	0.00%

iTeos Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	344	267	12	35
Gross Profit	0	0	0	344	266	11	33
Operating Income	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-
Net Income	-18	-22	-38	214	96	-112	-134
Net Profit Margin	0.00%	0.00%	0.00%	62.22%	36.11%	-894.34%	-384.04%

Global Institutional Holdings in iTeos Therapeutics Inc

Funds	Holdings
EcoR1 Capital, LLC	24.2%
BlackRock Inc	10.21%
TANG CAPITAL MANAGEMENT LLC	8.66%
Mpm Asset Management, LLC	6.2%
JPMorgan Chase & Co	4.49%

See all

Insights on iTeos Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 6 months, ITOS stock has moved up by 40.1%
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, -11.30M → 35.0M (in $), with an average increase of 132.3% per quarter
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.3% return, outperforming this stock by 171.6%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 57.5% return, outperforming this stock by 97.2%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -34.61M → -78.72M (in $), with an average decrease of 127.5% per quarter

About iTeos Therapeutics Inc

Organisation	iTeos Therapeutics Inc
E-voting on shares	Click here to vote

FAQs

What is iTeos Therapeutics Inc share price today?

iTeos Therapeutics Inc share price today is $10.17 as on August 29, 2025 at 1:29 am IST at the close of the market. iTeos Therapeutics Inc share today touched a day high of $10.17 and a low of $10.14.

What is the 52 week high and 52 week low for iTeos Therapeutics Inc share?

iTeos Therapeutics Inc share touched a 52 week high of $10.47 on July 21, 2025 and a 52 week low of $9.91 on June 20, 2025. iTeos Therapeutics Inc stock price today i.e. August 29, 2025 at 1:29 am IST is closed at $10.17,which is 2.87% down from its 52 week high and 2.62% up from its 52 week low.

How to invest in iTeos Therapeutics Inc Stock (ITOS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for iTeos Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in iTeos Therapeutics Inc Shares that will get you 0.1475 shares as per iTeos Therapeutics Inc share price of $10.17 per share as on August 29, 2025 at 1:29 am IST.

What is the minimum amount required to buy iTeos Therapeutics Inc Stock (ITOS) from India?

Indian investors can start investing in iTeos Therapeutics Inc (ITOS) shares with as little as ₹94.31 or $1 (as of June 21, 2026 at 5:11 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in iTeos Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on June 21, 2026 at 5:11 am IST). Based on iTeos Therapeutics Inc share’s latest price of $10.17 as on August 29, 2025 at 1:29 am IST, you will get 0.9833 shares of iTeos Therapeutics Inc. Learn more about fractional shares .